Cosmi Lorenzo, De Palma Raffaele, Santarlasci Veronica, Maggi Laura, Capone Manuela, Frosali Francesca, Rodolico Gabriella, Querci Valentina, Abbate Gianfranco, Angeli Roberta, Berrino Liberato, Fambrini Massimiliano, Caproni Marzia, Tonelli Francesco, Lazzeri Elena, Parronchi Paola, Liotta Francesco, Maggi Enrico, Romagnani Sergio, Annunziato Francesco
Department of Internal Medicine and DENOTHE Center, University of Florence, Florence 50134, Italy.
J Exp Med. 2008 Aug 4;205(8):1903-16. doi: 10.1084/jem.20080397. Epub 2008 Jul 28.
We demonstrate that CD161 is a highly up-regulated gene in human interleukin (IL) 17 T helper cell (Th17) clones and that all IL-17-producing cells are contained in the CD161(+) fraction of CD4(+) T cells present in the circulation or in inflamed tissues, although they are not CD1-restricted natural killer T cells. More importantly, we show that all IL-17-producing cells originate from CD161(+) naive CD4(+) T cells of umbilical cord blood, as well as of the postnatal thymus, in response to the combined activity of IL-1 beta and IL-23. These findings implicate CD161 as a novel surface marker for human Th17 cells and demonstrate the exclusive origin of these cells from a CD161(+)CD4(+) T cell progenitor.
我们证明,CD161是人类白细胞介素(IL)-17辅助性T细胞(Th17)克隆中高度上调的基因,并且所有产生IL-17的细胞都包含在循环系统或炎症组织中CD4(+) T细胞的CD161(+)亚群中,尽管它们不是CD1限制性自然杀伤T细胞。更重要的是,我们表明,所有产生IL-17的细胞都起源于脐带血以及出生后胸腺中的CD161(+)初始CD4(+) T细胞,这是对IL-1β和IL-23联合活性的响应。这些发现表明CD161是人类Th17细胞的一种新型表面标志物,并证明了这些细胞仅起源于CD161(+)CD4(+) T细胞祖细胞。